Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Corteva
(NYSE:CTVA)
Intraday
$54.92
0.22
[0.40%]
After-Hours
$54.92
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$54.92
0.22
[0.40%]
At close: Apr 26
$54.92
0
[0.00%]
After Hours: 4:00PM EDT
Get Report
Watch
Q1 2024 Earnings in 4 days from now on Wed May 1st, after the market close
Conference call scheduled in 5 days at 9:00 AM
Click to view the webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Corteva Stock (NYSE:CTVA)
Corteva Stock (NYSE: CTVA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, April 16, 2024
Oppenheimer Maintains Outperform on Corteva, Raises Price Target to $67
Benzinga Newsdesk
-
Apr 16, 2024, 8:58AM
Friday, April 12, 2024
Corteva shares are trading lower after JP Morgan downgraded the stock from Overweight to Neutral and lowered its price target from $58 to $57.
Benzinga Newsdesk
-
Apr 12, 2024, 10:42AM
JP Morgan Downgrades Corteva to Neutral, Lowers Price Target to $57
Benzinga Newsdesk
-
Apr 12, 2024, 9:32AM
Wednesday, April 10, 2024
Barclays Maintains Equal-Weight on Corteva, Raises Price Target to $58
Benzinga Newsdesk
-
Apr 10, 2024, 10:51AM
Tuesday, April 09, 2024
Analyst Expectations For Corteva's Future
Benzinga Insights
-
Apr 9, 2024, 9:01AM
Keybanc Maintains Overweight on Corteva, Raises Price Target to $66
Benzinga Newsdesk
-
Apr 9, 2024, 4:46AM
Monday, March 25, 2024
Ducera Growth Ventures Announces Strategic Collaboration With Corteva Catalyst To Leverage Ducera Growth's Proprietary Technology To Help Identify Companies For Investment Or Partnership
Benzinga Newsdesk
-
Mar 25, 2024, 8:04AM
Wednesday, March 06, 2024
AgPlenus Achieves Milestone In Collaboration With Corteva To Develop Novel Herbicides
Benzinga Newsdesk
-
Mar 6, 2024, 7:07AM
Friday, March 01, 2024
Expert Ratings For Corteva
Benzinga Insights
-
Mar 1, 2024, 3:02PM
Wolfe Research Initiates Coverage On Corteva with Outperform Rating
Benzinga Newsdesk
-
Mar 1, 2024, 12:40PM
Monday, February 12, 2024
Loop Capital Upgrades Corteva to Buy, Raises Price Target to $65
Benzinga Newsdesk
-
Feb 12, 2024, 7:05AM
Friday, February 02, 2024
Corteva Analysts Increase Their Forecasts After Upbeat Earnings
Avi Kapoor
-
Feb 2, 2024, 1:34PM
Oppenheimer Maintains Outperform on Corteva, Raises Price Target to $62
Benzinga Newsdesk
-
Feb 2, 2024, 1:06PM
Keybanc Maintains Overweight Rating for Corteva: Here's What You Need To Know
Benzinga Insights
-
Feb 2, 2024, 12:00PM
RBC Capital Maintains Outperform on Corteva, Raises Price Target to $64
Benzinga Newsdesk
-
Feb 2, 2024, 11:19AM
Keybanc Maintains Overweight on Corteva, Raises Price Target to $63
Benzinga Newsdesk
-
Feb 2, 2024, 9:30AM
Wells Fargo Maintains Overweight on Corteva, Raises Price Target to $65
Benzinga Newsdesk
-
Feb 2, 2024, 9:20AM
Barclays Maintains Equal-Weight on Corteva, Raises Price Target to $55
Benzinga Newsdesk
-
Feb 2, 2024, 8:09AM
Exane BNP Paribas Upgrades Corteva to Neutral, Announces $53 Price Target
Benzinga Newsdesk
-
Feb 2, 2024, 6:17AM
Thursday, February 01, 2024
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Feb 1, 2024, 1:17PM
Stocks Recoup Post-Fed Losses As Traders Challenge Powell, Regional Banks Crack, Gold Rises: What's Driving Markets Thursday?
Piero Cingari
-
Feb 1, 2024, 1:16PM
Corteva Stock Trades Higher Following Earnings Call
Erica Kollmann
-
Feb 1, 2024, 11:51AM
Eaton Posts Strong Results, Joins Ferrari, Boot Barn And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
-
Feb 1, 2024, 10:46AM
Mizuho Maintains Buy on Corteva, Lowers Price Target to $56-Report Released on 31 January 2024
Benzinga Newsdesk
-
Feb 1, 2024, 10:45AM
Corteva shares are trading higher after the company reported better-than-expected Q4 financial results, issued 2024 guidance and announced a $1 billion repurchase plan.
Benzinga Newsdesk
-
Feb 1, 2024, 9:18AM
Wednesday, January 31, 2024
Corteva Posts Solid Q4 Earnings, Issues FY 2024 Guidance, Announces $1.0B Repurchase Plan — Stock Rises
Ryan Gustafson
-
Jan 31, 2024, 6:00PM
Corteva Expects 2024 Net Sales Of $17.4B-$17.7B (Est. $17.608B), Adj EPS Of $2.70-$2.90 (Est. $3.01)
Benzinga Newsdesk
-
Jan 31, 2024, 5:07PM
Corteva Plans To Repurchase Approximately $1.0B Shares In 2024
Benzinga Newsdesk
-
Jan 31, 2024, 5:04PM
Corteva Q4 Adj EPS $0.15 Beats $0.06 Estimate, Sales $3.71B Beat $3.62B Estimate
Benzinga Newsdesk
-
Jan 31, 2024, 5:03PM
Earnings Scheduled For January 31, 2024
Benzinga Insights
-
Jan 31, 2024, 6:09AM
Tuesday, January 30, 2024
Corteva's Earnings Outlook
Benzinga Insights
-
Jan 30, 2024, 9:01AM
Monday, January 29, 2024
8 Analysts Assess Corteva: What You Need To Know
Benzinga Insights
-
Jan 29, 2024, 11:00AM
Thursday, January 11, 2024
Analyst Expectations For Corteva's Future
Benzinga Insights
-
Jan 11, 2024, 1:00PM
UBS Maintains Buy on Corteva, Lowers Price Target to $64
Benzinga Newsdesk
-
Jan 11, 2024, 10:52AM
Friday, December 29, 2023
Rising Tide of Lawsuits Over 'Forever Chemicals' Reportedly Predicted In 2024, Legal Landscape Altered By $11B Settlements In 2023
Vandana Singh
-
Dec 29, 2023, 8:43AM
Tuesday, December 19, 2023
ESG Stocks Take Center Stage As Damages From Climate-Related Events Rise Exponentially Within US
Surbhi Jain
-
Dec 19, 2023, 8:59AM
Thursday, December 14, 2023
Decoding Corteva's Options Activity: What's the Big Picture?
Benzinga Insights
-
Dec 14, 2023, 1:16PM
Wednesday, December 13, 2023
Ohio Resident Challenges Court Ruling Dismissing 'Forever Chemicals' Lawsuit Against 3M, Corteva And Others
Vandana Singh
-
Dec 13, 2023, 8:26AM
Thursday, December 07, 2023
S&P 500's Hidden Gems: 27 Stocks With 30%+ Upside Potential According To Wall Street Analyst Targets
Piero Cingari
-
Dec 7, 2023, 1:08PM
Wednesday, December 06, 2023
Top 3 Materials Stocks That Are Set To Fly In Q4
Lisa Levin
-
Dec 6, 2023, 7:49AM
Wednesday, November 29, 2023
Chemours, Along With Dupont And Corteva, Reach Settlement Agreement With The State Of Ohio For $110M To Resolve Claims Associated With Manufacture And Sale Of PFAS
Benzinga Newsdesk
-
Nov 29, 2023, 6:55AM
Tuesday, November 28, 2023
PFAS's Forever Problem: Ohio Lawsuit Against Chemical Companies Fizzles Out
Natan Ponieman
-
Nov 28, 2023, 2:47PM
Axios Reported Earlier 'Appeals Court Orders Dismissal Of Lawsuit Against Makers Of "Forever Chemicals"'
Benzinga Newsdesk
-
Nov 28, 2023, 9:45AM
Monday, November 27, 2023
The Latest Analyst Ratings for Corteva
Benzinga Insights
-
Nov 27, 2023, 10:00AM
CrowdStrike To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Monday
Lisa Levin
-
Nov 27, 2023, 7:22AM
Berenberg Downgrades Corteva to Hold, Lowers Price Target to $52
Benzinga Newsdesk
-
Nov 27, 2023, 4:53AM
Wednesday, November 22, 2023
Roth MKM Maintains Buy on Corteva, Lowers Price Target to $63
Benzinga Newsdesk
-
Nov 22, 2023, 10:13AM
Thursday, November 16, 2023
Massive Insider Trade At Corteva
Benzinga Insights
-
Nov 16, 2023, 10:04AM
Tuesday, November 14, 2023
(CTVA) - Analyzing Corteva's Short Interest
Benzinga Insights
-
Nov 14, 2023, 10:15AM
Barclays Downgrades Corteva to Equal-Weight, Lowers Price Target to $50
Benzinga Newsdesk
-
Nov 14, 2023, 5:43AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch